Kenvue Inc. (KVUE) SEC Filings & Earnings Calls

No new risks identified; filing is administrative.

Margin pressure from inflation, tariffs, and FX; pending merger creates uncertainty.

“The year-over-year change in both measures primarily reflects the impact from inflation, tariffs, as well as unfavorable transactional foreign exchange” · word for word

Tariff exposure on imported goods

“Changes in both Cost of sales and gross profit margin were driven by net input cost inflation, the impact of tariffs imposed on goods imported into the United States, and unfavorable changes in transactional foreign currency exchange rates, partially offset by benefits associated with our supply chain optimization initiatives.” · word for word

Input cost inflation

“Changes in both Cost of sales and gross profit margin were driven by net input cost inflation, the impact of tariffs imposed on goods imported into the United States, and unfavorable changes in transactional foreign currency exchange rates, partially offset by benefits associated with our supply chain optimization initiatives.” · word for word

Foreign exchange volatility

“Unfavorable changes in foreign currency exchange rates were cited as a headwind across multiple segments.” · word for word

Illness incidence variability

“Volume-related decreases were primarily attributable to the impact of lower incidences of illnesses affecting Allergy Care, pediatric Pain Care, and Cough and Cold as well as decreases in Digestive Health in EMEA and Asia Pacific.” · word for word

Tariff impact on margins

“Changes in both Cost of sales and gross profit margin were driven by benefits associated with our supply chain optimization initiatives, partially offset by net input cost inflation and the impact of tariffs imposed on goods imported into the United States.” · word for word

Input cost inflation

“Changes in both Cost of sales and gross profit margin were driven by benefits associated with our supply chain optimization initiatives, partially offset by net input cost inflation and the impact of tariffs imposed on goods imported into the United States.” · word for word

Self Care volume decline due to lower illness incidence

“Volume-related decreases were primarily attributable to the impact of lower incidences of illnesses affecting pediatric Pain Care as well as Cough and Cold.” · word for word

Volume decline in Self Care due to weak cold/flu season; reliance on seasonal demand.

“Weak cold and flu seasons across major markets weighed on the Self Care business.” · word for word

Pending merger creates execution risk and uncertainty; no guidance provided.

“Due to the pending transaction with Kimberly-Clark, the Company will not be providing forward-looking guidance.” · word for word

CFO transition risk; potential disruption in financial leadership.

“CFO stepping down; interim appointment.”

Pending transaction closing risk

“The Pending Transaction remains subject to the satisfaction or waiver of other customary closing conditions, including the receipt of a number of foreign regulatory approvals.” · word for word

Key executive turnover

“CFO Amit Banati announced voluntary departure in February 2026, with expected final date May 12, 2026.”

Demand weakness in China and US

“Net sales decline driven by retailer inventory reductions in the United States and reduced shipments in China.”

Restructuring execution risk; potential disruption to operations.

“the risk that the Company will not be able to implement the initiative as designed” · word for word

Pending transaction with Kimberly-Clark creates uncertainty; no guidance provided.

“Due to the pending transaction with Kimberly-Clark, the Company will not be providing forward-looking guidance.” · word for word

Tariff and FX headwinds impacting margins.

“inflationary, tariff, and transactional foreign exchange headwinds” · word for word

CFO departure during a pending transaction increases execution risk and may delay financial reporting or strategic decisions.

“the Company intends to appoint a successor who will serve as principal financial officer on an interim basis in light of the Company's pending transaction with Kimberly-Clark Corporation” · word for word

Regulatory approvals still pending; transaction close expected H2 2026 but subject to conditions.

“Transaction expected to close in the second half of 2026, subject to the receipt of regulatory approvals and satisfaction of other customary closing conditions.” · word for word

Litigation risk from multiple shareholder lawsuits seeking to enjoin merger; potential for delay or additional disclosure costs.

“Four complaints filed in different jurisdictions alleging material omissions in proxy statement; demand letters also received.”

Tariff exposure

“we estimate incremental gross tariff exposure of approximately $150 million annualized.” · word for word

Goodwill impairment risk

“Based on the results of the assessment, the estimated fair value of the Skin Health and Beauty reporting unit exceeded the carrying value by approximately 10%; therefore, no impairment charge was recorded for the fiscal three months ended September 28, 2025.” · word for word

Acetaminophen regulatory risk

“The U.S. Food and Drug Administration (“FDA”) also stated it initiated the process for a label change for acetaminophen and issued a notice to physicians.” · word for word

Merger execution risk

“The Transaction is expected to close in the second half of 2026 and is conditioned on the approval by the Company’s stockholders of a proposal to adopt the Merger Agreement and by K-C stockholders of a proposal to approve the issuance of K-C common stock in connection with the First Merger, as well as the satisfaction or waiver of other customary closing con” · word for word

Volume decline and trade inventory reductions pressuring top line.

“Organic sales decline of 4.4% driven by a 4.0% volume decrease; trade inventory reductions in certain customers.”

Tariff and inflationary headwinds impacting margins.

“inflationary, tariff, and foreign exchange headwinds.” · word for word

Merger uncertainty may distract management and impact operations.

“Merger agreement with Kimberly-Clark announced concurrently.”

Merger execution risk; regulatory approvals required.

“Transaction subject to regulatory approvals and stockholder votes.”

Potential for deal termination or renegotiation.

“Standard merger agreement risks.”